<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Fuad El-Hibri Network &#187; Fuad Elhibri</title>
	<atom:link href="http://fuad-elhibri.net/category/fuad-elhibri/feed/" rel="self" type="application/rss+xml" />
	<link>http://fuad-elhibri.net</link>
	<description>Network of Fuad El-Hibri</description>
	<lastBuildDate>Mon, 30 Aug 2010 06:38:52 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript</title>
		<link>http://fuad-elhibri.net/2009/08/13/emergent-biosolutions-inc-q2-2009-earnings-call-transcript/</link>
		<comments>http://fuad-elhibri.net/2009/08/13/emergent-biosolutions-inc-q2-2009-earnings-call-transcript/#comments</comments>
		<pubDate>Thu, 13 Aug 2009 17:30:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Chairman of the Board]]></category>
		<category><![CDATA[Chairman of the Board of Directors]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Emergent]]></category>
		<category><![CDATA[Emergent BioSolutions]]></category>
		<category><![CDATA[Executive Profile]]></category>
		<category><![CDATA[Fuad El-Hibri]]></category>
		<category><![CDATA[Fuad Elhibri]]></category>
		<category><![CDATA[Investor relations]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[Chief financial officer]]></category>
		<category><![CDATA[Chief operating officer]]></category>
		<category><![CDATA[finance]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Vice president]]></category>

		<guid isPermaLink="false">http://fuad-elhibri.net/?p=82</guid>
		<description><![CDATA[Emergent BioSolutions Inc., (EBS)
Q2 2009 Earnings Call
August 6, 2009 5:00 pm ET
 
Executives
Robert G. Burrows &#8211; Vice President, Investor Relations
Fuad El-Hibri &#8211; Chairman of the Board, Chief Executive Officer
R. Don Elsey &#8211; Chief Financial Officer
Daniel J. Abdun-Nabi &#8211; President, Chief Operating Officer
W. James Jackson, Ph.D. &#8211; Senior Vice President and Chief Scientific Officer
 
Analysts
Eric Schmidt [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;">Emergent BioSolutions Inc., (<a title="More opinion and analysis of EBS" href="http://seekingalpha.com/symbol/ebs">EBS</a>)</p>
<p style="text-align: justify;">Q2 2009 Earnings Call</p>
<p style="text-align: justify;">August 6, 2009 5:00 pm ET</p>
<p style="text-align: justify;"><strong> </strong></p>
<p style="text-align: justify;"><strong>Executives</strong></p>
<p style="text-align: justify;">Robert G. Burrows &#8211; Vice President, <a class="zem_slink" title="Investor relations" rel="wikipedia" href="http://en.wikipedia.org/wiki/Investor_relations">Investor Relations</a></p>
<p style="text-align: justify;"><a href="http://seekingalpha.com/article/154549-emergent-biosolutions-inc-q2-2009-earnings-call-transcript">Fuad El-Hibri</a> &#8211; <a class="zem_slink" title="Chairman" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chairman">Chairman of the Board</a>, <a class="zem_slink" title="Chief executive officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_executive_officer">Chief Executive Officer</a></p>
<p style="text-align: justify;">R. Don Elsey &#8211; <a class="zem_slink" title="Chief financial officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_financial_officer">Chief Financial Officer</a></p>
<p style="text-align: justify;">Daniel J. Abdun-Nabi &#8211; President, <a class="zem_slink" title="Chief operating officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_operating_officer">Chief Operating Officer</a></p>
<p style="text-align: justify;">W. James Jackson, Ph.D. &#8211; <a class="zem_slink" title="Vice president" rel="wikipedia" href="http://en.wikipedia.org/wiki/Vice_president">Senior Vice President</a> and <a class="zem_slink" title="Chief science officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_science_officer">Chief Scientific Officer</a></p>
<p style="text-align: justify;"><strong> </strong></p>
<p style="text-align: justify;"><strong>Analysts</strong></p>
<p style="text-align: justify;">Eric Schmidt &#8211; Cowen &amp; Company</p>
<p style="text-align: justify;">David Moskowitz &#8211; Caris &amp; Company</p>
<p style="text-align: justify;">Mona Ashiya &#8211; J.P. Morgan</p>
<p style="text-align: justify;">Sean Long – Kennedy Capital Management</p>
<p style="text-align: justify;"><strong> </strong></p>
<p style="text-align: justify;"><strong>Presentation</strong></p>
<p style="text-align: justify;"><strong> </strong></p>
<p style="text-align: justify;"><strong>Operator</strong></p>
<p style="text-align: justify;">Welcome to the Emergent BioSolutions Incorporated second quarter 2009 financial results conference call. (Operator Instructions) I would now like to turn the call over to Mr. Robert Burrows.</p>
<p style="text-align: justify;"><strong>Robert Burrows</strong></p>
<p style="text-align: justify;">Good afternoon ladies and gentlemen. My name is Robert Burrows, Vice President of Investor Relations for Emergent. Thank you for joining us today as we discuss Emergent BioSolutions financial results for the second quarter and first six months of 2009. As is customary, our call today is open to all participants. In addition, the call is being recorded and is copyrighted by Emergent BioSolutions&#8230;.</p>
<div class="zemanta-pixie" style="margin-top: 10px; height: 15px; text-align: justify;"><a class="zemanta-pixie-a" title="Reblog this post [with Zemanta]" href="http://reblog.zemanta.com/zemified/4e6f1090-3aa1-46cb-965a-70dde540160c/"><img class="zemanta-pixie-img" style="border: medium none; float: right;" src="http://img.zemanta.com/reblog_e.png?x-id=4e6f1090-3aa1-46cb-965a-70dde540160c" alt="Reblog this post [with Zemanta]" /></a><span class="zem-script more-related pretty-attribution"><script src="http://static.zemanta.com/readside/loader.js" type="text/javascript"></script></span></div>
]]></content:encoded>
			<wfw:commentRss>http://fuad-elhibri.net/2009/08/13/emergent-biosolutions-inc-q2-2009-earnings-call-transcript/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Maker of anthrax vaccine discusses challenges of marketing overseas</title>
		<link>http://fuad-elhibri.net/2009/08/04/maker-of-anthrax-vaccine-discusses-challenges-of-marketing-overseas/</link>
		<comments>http://fuad-elhibri.net/2009/08/04/maker-of-anthrax-vaccine-discusses-challenges-of-marketing-overseas/#comments</comments>
		<pubDate>Tue, 04 Aug 2009 13:22:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioPort]]></category>
		<category><![CDATA[BioThrax]]></category>
		<category><![CDATA[Chairman of the Board of Directors]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Emergent]]></category>
		<category><![CDATA[Emergent BioSolutions]]></category>
		<category><![CDATA[Fuad El-Hibri]]></category>
		<category><![CDATA[Fuad Elhibri]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Insurance]]></category>
		<category><![CDATA[Master of Business Administration]]></category>
		<category><![CDATA[Risk management]]></category>
		<category><![CDATA[S.C. Johnson Graduate School of Management]]></category>

		<guid isPermaLink="false">http://fuad-elhibri.net/?p=69</guid>
		<description><![CDATA[On March 9, MBA students taking International Political Risk Management, a course taught by Elena  Iankova, a lecturer at the S.C. Johnson Graduate School of  Management, heard Fuad El-Hibri, chairman and CEO of Bioport&#8217;s parent  company, Emergent BioSolutions Inc., discuss the hurdles his firm faces  in making and marketing its products [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;">On March 9, <a class="zem_slink" title="Master of Business Administration" rel="wikipedia" href="http://en.wikipedia.org/wiki/Master_of_Business_Administration">MBA</a> students taking International Political <a class="zem_slink" title="Risk management" rel="wikipedia" href="http://en.wikipedia.org/wiki/Risk_management">Risk Management</a>, a course taught by Elena  Iankova, a lecturer at the <a class="zem_slink" title="S.C. Johnson Graduate School of Management" rel="homepage" href="http://www.johnson.cornell.edu/">S.C. Johnson Graduate School of  Management</a>, heard<a href="http://www.news.cornell.edu/Chronicle/05/3.17.05/El-Hibri_cover.html"> Fuad El-Hibri</a>, <a class="zem_slink" title="Chief executive officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_executive_officer">chairman and CEO</a> of Bioport&#8217;s parent  company, <a class="zem_slink" title="NYSE: EBS" rel="stockexchange" href="http://finance.yahoo.com/q?s=EBS">Emergent BioSolutions</a> Inc., discuss the hurdles his firm faces  in making and <a class="zem_slink" title="Marketing" rel="wikipedia" href="http://en.wikipedia.org/wiki/Marketing">marketing</a> its products abroad.</p>
<p style="text-align: justify;"><img src="http://www.news.cornell.edu/Chronicle/05/3.17.05/El-Hibri.jpg" alt="http://www.news.cornell.edu/Chronicle/05/3.17.05/El-Hibri.jpg" /></p>
<p style="text-align: justify;">His guest lecture was titled &#8220;Managing International Risk in the Bio-Defense and Telecommunications Industries.&#8221;</p>
<p style="text-align: justify;">Using his own company as an example, El-Hibri outlined six areas of risk in international <a class="zem_slink" title="Business" rel="wikipedia" href="http://en.wikipedia.org/wiki/Business">business</a>, among them export/import regulations, <a class="zem_slink" title="Politics" rel="wikipedia" href="http://en.wikipedia.org/wiki/Politics">politics</a> at home and abroad and financial issues. Much of his talk focused on political issues ranging from export regulations to how to deal with foreign governments.</p>
<div class="zemanta-pixie" style="margin-top: 10px; height: 15px; text-align: justify;"><a class="zemanta-pixie-a" title="Reblog this post [with Zemanta]" href="http://reblog.zemanta.com/zemified/51c4b0e3-e29f-483d-ac50-6ab2efa1597d/"><img class="zemanta-pixie-img" style="border: medium none; float: right;" src="http://img.zemanta.com/reblog_e.png?x-id=51c4b0e3-e29f-483d-ac50-6ab2efa1597d" alt="Reblog this post [with Zemanta]" /></a><span class="zem-script more-related pretty-attribution"><script src="http://static.zemanta.com/readside/loader.js" type="text/javascript"></script></span></div>
]]></content:encoded>
			<wfw:commentRss>http://fuad-elhibri.net/2009/08/04/maker-of-anthrax-vaccine-discusses-challenges-of-marketing-overseas/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fuad El-Hibri Ernst &amp; Young Entrepreneur of the Year 2009 Award Finalist</title>
		<link>http://fuad-elhibri.net/2009/07/06/fuad-el-hibri-ernst-young-entrepreneur-of-the-year-2009-award-finalist/</link>
		<comments>http://fuad-elhibri.net/2009/07/06/fuad-el-hibri-ernst-young-entrepreneur-of-the-year-2009-award-finalist/#comments</comments>
		<pubDate>Mon, 06 Jul 2009 01:41:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioThrax]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Emergent BioSolutions]]></category>
		<category><![CDATA[Fuad El-Hibri]]></category>
		<category><![CDATA[Fuad Elhibri]]></category>
		<category><![CDATA[Entrepreneur]]></category>
		<category><![CDATA[Ewing Marion Kauffman Foundation]]></category>
		<category><![CDATA[HSBC Bank]]></category>
		<category><![CDATA[Ritz-Carlton]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://fuad-elhibri.net/?p=32</guid>
		<description><![CDATA[Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst &#38; Young Entrepreneur of the Year 2009 Award Finalist in Greater Washington
ROCKVILLE, Md.&#8211;(BUSINESS WIRE)&#8211;Emergent BioSolutions Inc. (NYSE:EBS) announced today that its chairman and chief executive officer, Mr. Fuad El-Hibri, is a finalist for the Ernst &#38; Young Entrepreneur of the Year® 2009 Award in the [...]]]></description>
			<content:encoded><![CDATA[<div class="post-body entry-content" style="text-align: justify;"><strong><a class="zem_slink" title="NYSE: EBS" rel="stockexchange" href="http://finance.yahoo.com/q?s=EBS">Emergent BioSolutions</a> Chairman and CEO, Mr. Fuad El-Hibri, Named <a class="zem_slink" title="Ernst &amp; Young" rel="homepage" href="http://www.ey.com/">Ernst &amp; Young</a> Entrepreneur of the Year 2009 Award Finalist in Greater Washington</strong></p>
<p>ROCKVILLE, Md.&#8211;(BUSINESS WIRE)&#8211;Emergent BioSolutions Inc. (NYSE:EBS) announced today that its chairman and <a class="zem_slink" title="Chief executive officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_executive_officer">chief executive officer</a>, Mr. <a href="http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&amp;newsId=20090508005173&amp;newsLang=en">Fuad El-Hibri</a>, is a finalist for the Ernst &amp; <a class="zem_slink" title="Entrepreneur" rel="wikipedia" href="http://en.wikipedia.org/wiki/Entrepreneur">Young Entrepreneur</a> of the Year® 2009 Award in the Greater Washington region. According to Ernst &amp; Young LLP, the awards program recognizes <a class="zem_slink" title="Entrepreneur" rel="wikipedia" href="http://en.wikipedia.org/wiki/Entrepreneur">entrepreneurs</a> who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities. Mr. El-Hibri was selected as a finalist from nearly 100 nominations by a panel of independent judges. Award winners will be announced at a special gala event on June 18 at the <a class="zem_slink" title="Ritz-Carlton" rel="wikipedia" href="http://en.wikipedia.org/wiki/Ritz-Carlton">Ritz-Carlton</a>, Tysons Corner in Virginia.</p>
<p>“It is an honor to be chosen as a finalist for the Ernst &amp; Young Entrepreneur of the Year Award,” said <a href="http://xyiencediet.blogspot.com/2009/06/fuad-el-hibri-ernst-young-entrepreneur.html">Mr. Fuad El-Hibri</a>. “I am proud of the entrepreneurial spirit, commitment, and collaboration that prevail at Emergent, which are key factors to our company’s success. This recognition represents the contributions of each and every member of the Emergent Team as we work together in pursuit of our company mission – to protect life.”</p>
<p>Mr. El-Hibri was also a finalist for the Greater Washington region in 2007. The Ernst &amp; Young Entrepreneur of the Year awards program celebrates its 23rd anniversary this year. The program has expanded to recognize business leaders in over 135 cities in 50 countries throughout the world.</p>
<p><strong>About Emergent BioSolutions Inc.</strong><br />
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax® (<a class="zem_slink" title="Anthrax vaccines" rel="wikipedia" href="http://en.wikipedia.org/wiki/Anthrax_vaccines">Anthrax Vaccine</a> Adsorbed), is the only vaccine licensed by the <a class="zem_slink" title="U.S. Food and Drug Administration" rel="homepage" href="http://www.fda.gov/">U.S. Food and Drug Administration</a> for the prevention of anthrax. Emergent’s development pipeline includes programs focused on anthrax, botulism, tuberculosis, typhoid, hepatitis B and chlamydia. Additional information may be found at www.emergentbiosolutions.com.</p>
<p><strong>About Ernst &amp; Young’s Entrepreneur of the Year® Awards Program</strong><br />
Ernst &amp; Young’s Entrepreneur of the Year® Award is the world’s most prestigious business award for entrepreneurs. The award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, the Ernst &amp; Young Entrepreneur of the Year® award celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.</p>
<p><strong>Sponsors</strong><br />
Founded and produced by Ernst &amp; Young LLP, the Entrepreneur of the Year awards are pleased to have the <a class="zem_slink" title="Ewing Marion Kauffman Foundation" rel="wikipedia" href="http://en.wikipedia.org/wiki/Ewing_Marion_Kauffman_Foundation">Ewing Marion Kauffman Foundation</a> and SAP <a class="zem_slink" title="United States" rel="geolocation" href="http://maps.google.com/maps?ll=38.8833333333,-77.0166666667&amp;spn=10.0,10.0&amp;q=38.8833333333,-77.0166666667%20%28United%20States%29&amp;t=h">America</a> as national sponsors.</p>
<p>In Greater Washington, sponsors include <a class="zem_slink" title="HSBC Bank (Europe)" rel="homepage" href="http://www.hsbc.co.uk/">HSBC Bank</a>, <a class="zem_slink" title="Pillsbury Winthrop Shaw Pittman" rel="homepage" href="http://www.pillsburylaw.com/">Pillsbury Law</a>, Reznick Group, Lockton Companies and the Washington Business Journal.</div>
<div class="post-footer-line post-footer-line-1" style="text-align: justify;"><span class="post-author vcard"> Posted by <span class="fn">Chris Abraham</span> </span> <span class="post-timestamp"> at <a class="timestamp-link" title="permanent link" rel="bookmark" href="http://xyiencediet.blogspot.com/2009/06/fuad-el-hibri-ernst-young-entrepreneur.html"><abbr class="published" title="2009-06-17T08:33:00-07:00">8:33 AM</abbr></a> </span> <span class="reaction-buttons"> </span> <span class="star-ratings"> </span> <span class="post-comment-link"> </span> <span class="post-backlinks post-comment-link"> </span> <span class="post-icons"> <span class="item-control blog-admin pid-1665924543"> <a title="Edit Post" href="http://www.blogger.com/post-edit.g?blogID=4411513656709856049&amp;postID=5469601764090140359"> <img class="icon-action" src="http://www.blogger.com/img/icon18_edit_allbkg.gif" alt="" width="18" height="18" /> </a> </span> </span></div>
<div class="post-footer-line post-footer-line-2" style="text-align: justify;"><span class="post-labels"> Labels: <a rel="tag" href="http://xyiencediet.blogspot.com/search/label/Business">Business</a>, <a rel="tag" href="http://xyiencediet.blogspot.com/search/label/Entrepreneur">Entrepreneur</a>, <a rel="tag" href="http://xyiencediet.blogspot.com/search/label/Ewing%20Marion%20Kauffman%20Foundation">Ewing Marion Kauffman Foundation</a>, <a rel="tag" href="http://xyiencediet.blogspot.com/search/label/HSBC%20Bank">HSBC Bank</a>, <a rel="tag" href="http://xyiencediet.blogspot.com/search/label/Ritz-Carlton">Ritz-Carlton</a>, <a rel="tag" href="http://xyiencediet.blogspot.com/search/label/U.S.%20Food%20and%20Drug%20Administration">U.S. Food and Drug Administration</a>, <a rel="tag" href="http://xyiencediet.blogspot.com/search/label/United%20States">United States</a>, <a rel="tag" href="http://xyiencediet.blogspot.com/search/label/Virginia">Virginia</a> </span></div>
<div class="zemanta-pixie" style="margin-top: 10px; height: 15px; text-align: justify;"><a class="zemanta-pixie-a" title="Reblog this post [with Zemanta]" href="http://reblog.zemanta.com/zemified/2ceecb6c-0cd4-4bc8-8801-0658cecfb122/"><img class="zemanta-pixie-img" style="border: medium none; float: right;" src="http://img.zemanta.com/reblog_e.png?x-id=2ceecb6c-0cd4-4bc8-8801-0658cecfb122" alt="Reblog this post [with Zemanta]" /></a><span class="zem-script more-related pretty-attribution"><script src="http://static.zemanta.com/readside/loader.js" type="text/javascript"></script></span></div>
]]></content:encoded>
			<wfw:commentRss>http://fuad-elhibri.net/2009/07/06/fuad-el-hibri-ernst-young-entrepreneur-of-the-year-2009-award-finalist/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fuad El-Hibri  &#8211; fuad elhibri  PeoplePond</title>
		<link>http://fuad-elhibri.net/2009/07/06/fuad-el-hibri-fuad-elhibri-peoplepond/</link>
		<comments>http://fuad-elhibri.net/2009/07/06/fuad-el-hibri-fuad-elhibri-peoplepond/#comments</comments>
		<pubDate>Mon, 06 Jul 2009 01:32:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Emergent BioSolutions]]></category>
		<category><![CDATA[Fuad El-Hibri]]></category>
		<category><![CDATA[Fuad Elhibri]]></category>
		<category><![CDATA[PeoplePond]]></category>

		<guid isPermaLink="false">http://fuad-elhibri.net/?p=25</guid>
		<description><![CDATA[ Mr. Fuad El-Hibri is the Chairman and Chief Executive Officer of Emergent BioSolutions Inc. (Emergent). family, health, polo, music, telecommunications, telecom, science, technology, banking, mergers, acquisitions, management, academia
]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;"><a href="http://www.peoplepond.com/fuadelhibri"> Mr. Fuad El-Hibri</a> is the Chairman and Chief Executive Officer of Emergent BioSolutions Inc. (Emergent). family, health, polo, music, telecommunications, telecom, science, technology, banking, mergers, acquisitions, management, academia</p>
]]></content:encoded>
			<wfw:commentRss>http://fuad-elhibri.net/2009/07/06/fuad-el-hibri-fuad-elhibri-peoplepond/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
